Review article · 2023

Advances in Development of Selective Antitumor Inhibitors That Target PARP-1

Fang Liu, Jia‐Shu Chen, Xiangqian Li, Ruihua Liu, Yiting Zhang, Chenxia Gao, Dayong Shi

Journal of Medicinal Chemistry, 66(24), 16464–16483 · Published 13 December 2023 · DOI 10.1021/acs.jmedchem.3c00865

View at the publisherCite this paper

In brief

“Advances in Development of Selective Antitumor Inhibitors That Target PARP-1” is a 2023 review article by Fang Liu and 6 co-authors, published in Journal of Medicinal Chemistry. OpenAlex counts 39 citations as of 22 November 2026, which puts it in the top 2% of works published in 2023 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
39
Most cited in
2025 (14)
Field-weighted impact
1.17
References
72
Authors
7

Abstract

Cancer is a major threat to the lives and health of people around the world, and the development of effective antitumor drugs that exhibit fewer toxic effects is an important aspect of cancer treatment. PARP inhibitors are antitumor drugs that target pathways involved in DNA-damage repair. The currently approved PARP inhibitors include olaparib, niraparib, rucaparib… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Liu, F., Chen, J., Li, X., Liu, R., Zhang, Y., Gao, C., & Shi, D. (2023). Advances in Development of Selective Antitumor Inhibitors That Target PARP-1. Journal of Medicinal Chemistry, 66(24), 16464–16483. https://doi.org/10.1021/acs.jmedchem.3c00865

MLA 9

Liu, Fang, et al. “Advances in Development of Selective Antitumor Inhibitors That Target PARP-1.” Journal of Medicinal Chemistry, vol. 66, no. 24, 2023, pp. 16464–16483. https://doi.org/10.1021/acs.jmedchem.3c00865.

Chicago

Liu, Fang, Jia‐Shu Chen, Xiangqian Li, Ruihua Liu, Yiting Zhang, Chenxia Gao, and Dayong Shi. 2023. “Advances in Development of Selective Antitumor Inhibitors That Target PARP-1.” Journal of Medicinal Chemistry 66 (24): 16464–16483. https://doi.org/10.1021/acs.jmedchem.3c00865.

Harvard

Liu, F. et al. (2023) ‘Advances in Development of Selective Antitumor Inhibitors That Target PARP-1’, Journal of Medicinal Chemistry, 66(24), pp. 16464–16483. doi:10.1021/acs.jmedchem.3c00865.

IEEE

F. Liu et al., “Advances in Development of Selective Antitumor Inhibitors That Target PARP-1,” Journal of Medicinal Chemistry, vol. 66, no. 24, pp. 16464–16483, 2023, doi: 10.1021/acs.jmedchem.3c00865.

BibTeX

@article{liu2023advances,
  title     = {{Advances in Development of Selective Antitumor Inhibitors That Target PARP-1}},
  author    = {Liu, Fang and Chen, Jia‐Shu and Li, Xiangqian and Liu, Ruihua and Zhang, Yiting and Gao, Chenxia and Shi, Dayong},
  journal   = {Journal of Medicinal Chemistry},
  year      = {2023},
  volume    = {66},
  number    = {24},
  pages     = {16464--16483},
  doi       = {10.1021/acs.jmedchem.3c00865},
  url       = {https://doi.org/10.1021/acs.jmedchem.3c00865}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20241313
20251414
20261212

Its field-weighted citation impact is 1.17: it has been cited 1.17 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy

  • PARP-1 inhibitors
  • DNA repair
  • PARP inhibitors
  • olaparib
  • niraparib
  • rucaparib
  • talazoparib
  • pamiparib

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Liu, F., Chen, J., Li, X., Liu, R., Zhang, Y., Gao, C., & Shi, D. (2023). Advances in Development of Selective Antitumor Inhibitors That Target PARP-1. Journal of Medicinal Chemistry, 66(24), 16464–16483. https://doi.org/10.1021/acs.jmedchem.3c00865

How many times has this paper been cited?

39 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Fang Liu, Jia‐Shu Chen, Xiangqian Li, Ruihua Liu, Yiting Zhang, Chenxia Gao, Dayong Shi.

What is the DOI of this paper?

10.1021/acs.jmedchem.3c00865, permanently at https://doi.org/10.1021/acs.jmedchem.3c00865. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.